Stay updated on Treprostinil Inhalation Powder in PAH Clinical Trial
Sign up to get notified when there's something new on the Treprostinil Inhalation Powder in PAH Clinical Trial page.

Latest updates to the Treprostinil Inhalation Powder in PAH Clinical Trial page
- Check5 days agoChange DetectedA new Study Status entry was added in the history on 2026-03-30, and an entry dated 2025-04-10 was deleted.SummaryDifference0.3%

- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedThe history now includes a new revision, v3.5.0, and the older revision v3.4.3 was removed from the history.SummaryDifference0.1%

- Check27 days agoChange DetectedThe history now shows a new revision v3.4.3 and removes the previous v3.4.2.SummaryDifference0.1%

- Check55 days agoChange DetectedA new Revision: v3.4.2 was added to the history; Revision: v3.4.1 and the government funding notice were removed.SummaryDifference0.5%

- Check62 days agoChange DetectedAdded a government funding lapse notice with the NIH Clinical Center status and a pointer to opm.gov; updated the site revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check70 days agoChange DetectedAdded UI text for showing the glossary and color-coding changes (green/red highlights) and the revision note 'Revision: v3.4.0'. Removed the older notes 'No FEAR Act data' and 'Revision: v3.3.4'.SummaryDifference0.6%

Stay in the know with updates to Treprostinil Inhalation Powder in PAH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Treprostinil Inhalation Powder in PAH Clinical Trial page.